在心力衰竭中化物范式的转变:从被忽视的离子到精确的利尿疗法的基石
Jaime Mazón-Ruiz1, Eduardo Josué Banegas-Deras1, Jose María Fernández-Rodríguez2
1Nephrology Department, Hospital Carmen y Severo Ochoa, Cangas del Narcea, Spain.
European journal of heart failure
|October 29, 2025
概括
心力衰竭中低化物水平会使症状和结果恶化. 通过向疗法恢复化物平衡可能会改善流体管理和患者的预后.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 电解质生理学 电解质生理学
背景情况:
- 化物是一种主要的细胞外离子,对生理平衡至关重要.
- 在心力衰竭 (HF) 中,低血症通过影响功能和神经激素活动,促进疾病的进展.
- 血清化物水平较低与HF患者的死亡率增加和尿药反应不佳有关.
研究的目的:
- 审查化物在心力衰竭中的病理生理学和临床意义.
- 检查化物平衡恢复和改善利尿反应的新兴治疗策略.
主要方法:
- 文献综述综合了有关化物在HF病理生理学和治疗中的作用的现有研究.
- 对调查平衡干预措施的临床试验的分析.
主要成果:
- 在HF中,低血症加剧了再吸收,代谢性,氨酸-氨酸-阿尔多斯特系统的激活,恶化了液体保留和利尿性耐药性.
- 新出现的证据表明,低化物独立与较高的死亡率和降低的脱效率有关.
- 临床试验 (SMAC-HF,SALT-HF) 在低血性HF患者中显示了化物集中治疗的潜在益处.
结论:
- 低血是心力衰竭管理的关键,可修改的因素,而不仅仅是旁观者.
- 化物平衡的向提供了一个有希望的策略,用于个性化的脱血疗法,并改善了HF的结果.
- 化物引导的管理可能代表了处理高频相关拥堵和体积过载的范式转变.
相关概念视频
Heart Failure Drugs: Diuretics
789
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
789
Heart Failure V: Medical Management
209
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
209
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
915
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
915
Heart Failure VI: Adjunct Therapies
246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246
Antihypertensive Drugs: Thiazide-Class Diuretics
1.6K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.6K
Heart Failure II: Pathophysiology
704
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704

